Research further demonstrates COVID-19 vaccination as an important clinical strategy to help protect vulnerable patients from infection DENVER, Feb. 17, 2022 /PRNewswire/ — Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson… Read more

Company highlights major milestones achieved over the past year DENVER, Jan. 12, 2022 /PRNewswire/ — DaVita today celebrated its teammates (employees) for their contributions that helped improve the lives of kidney patients, advance innovation… Read more

Research supports vaccination as an important clinical strategy to help protect vulnerable patients from virus infection. DENVER, Nov. 29, 2021 /PRNewswire/ — Dialysis patients who received mRNA COVID-19 vaccines had a lower risk… Read more

Groundbreaking research holds promise for new clinical management techniques and understanding of vaccine immune response in kidney patients DENVER, Nov. 4, 2021 – DaVita Clinical Research (DCR) will present eight… Read more

Latest research supports improvements in care delivery and patient outcomes DENVER, Oct. 22, 2020 /PRNewswire/ — DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the… Read more

DaVita Clinical Research investigating presence of COVID-19 antibodies and genetic contributions to infection severity in patients DENVER, (Aug. 19, 2020) – DaVita Clinical Research (DCR), a subsidiary of DaVita Inc.,… Read more

Highlights a year of clinical excellence, innovation and community support DENVER, Jan. 22, 2020 /PRNewswire/ — DaVita is closing the decade by highlighting its milestones and achievements from 2019. Javier Rodriguez took the… Read more

DaVita clinical leaders push for innovation through new research  MINNEAPOLIS, Nov. 5, 2019 – DaVita Clinical Research (DCR) is set to present 10 research abstracts from company representatives and medical… Read more

Teammates Deliver Clinical Excellence, Improved Patient Care, Innovation, Robust Partnerships, Community Leadership DENVER, Dec. 26, 2018 /PRNewswire/ — DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care… Read more

DaVita physicians and clinical leaders to present on pertinent nephrology topics and research MINNEAPOLIS, Oct. 23, 2018 /PRNewswire/ — DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., (NYSE: DVA), will present 19 research… Read more